Figure 8.

Kaplan-Meier curves of PFS in LN-negative and positive patients. Note that in both LN(−) and LN(+) patients, an absence of stromal Cav-1 still remains a significant predictor of progression-free outcome. However, the results were most dramatic in LN(+) patients, where an absence of stromal Cav-1 is associated with an ∼11.5-fold reduction in 5-year progression-free survival. There were 50 patients in the LN(−) group and 54 patients in the LN(+) group. P values are as shown. 5-year PFS is indicated by an arrow.